InsiderTrades.com logo
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

GANX Insider Trading

Insider Ownership Percentage: 11.70%
Insider Buying (Last 12 Months): $201,084.00
Insider Selling (Last 12 Months): $506.76

Gain Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Gain Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Gain Therapeutics Share Price & Price History

Current Price: $1.72
Price Change: ▲ Price Increase of +0.1 (6.17%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for GANX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

Gain Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/9/2024Gene MackCEOBuy14,400$1.01$14,544.0014,400View SEC Filing Icon  
8/9/2024Khalid IslamChairmanBuy50,000$1.00$50,000.0050,000View SEC Filing Icon  
7/1/2024Eric I RichmanDirectorBuy17,000$1.22$20,740.00289,629View SEC Filing Icon  
3/28/2024Jeffrey Scott RileyDirectorBuy30,000$3.86$115,800.0030,000View SEC Filing Icon  
12/21/2023Matthias AlderCEOSell206$2.46$506.765,286View SEC Filing Icon  
5/25/2022Eric I RichmanCEOBuy2,482$2.58$6,403.56217,729View SEC Filing Icon  
5/19/2022Eric I RichmanCEOBuy4,000$2.71$10,840.00205,991View SEC Filing Icon  
See Full Table
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

SEC Filings (Institutional Ownership Changes) for Gain Therapeutics (NASDAQ:GANX)

11.97% of Gain Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GANX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Gain Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC271,972$0.48M0.0%+48.0%1.065%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC118,700$0.15M0.0%+154.2%0.658%Search for SEC Filing on Google Icon
8/9/2024Warberg Asset Management LLC51,600$66K0.0%N/A0.286%Search for SEC Filing on Google Icon
8/3/2024Hohimer Wealth Management LLC330,000$0.42M0.1%N/A1.828%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates23,788$78K0.0%-29.6%0.184%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates33,400$0.15M0.0%+67.0%0.271%Search for SEC Filing on Google Icon
5/8/2023CM Management LLC90,000$0.43M0.5%-18.2%0.740%Search for SEC Filing on Google Icon
5/2/2023Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105%Search for SEC Filing on Google Icon
4/14/2023Raymond James & Associates20,000$96K0.0%-16.7%0.168%Search for SEC Filing on Google Icon
2/9/2023CM Management LLC110,000$0.34M0.4%-12.0%0.926%Search for SEC Filing on Google Icon
1/17/2023Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158%Search for SEC Filing on Google Icon
11/17/2022Telemetry Investments L.L.C.150,000$0.49M0.6%-6.3%1.263%Search for SEC Filing on Google Icon
10/25/2022Raymond James & Associates24,000$78K0.0%N/A0.202%Search for SEC Filing on Google Icon
10/12/2022Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC125,000$0.51M0.4%+38.9%1.052%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085%Search for SEC Filing on Google Icon
2/2/2022CM Management LLC90,000$0.49M0.4%+39.9%0.758%Search for SEC Filing on Google Icon
11/16/2021Telemetry Investments L.L.C.96,232$0.72M1.0%+217.7%0.810%Search for SEC Filing on Google Icon
11/15/2021Veritable L.P.25,064$0.19M0.0%N/A0.211%Search for SEC Filing on Google Icon
11/9/2021Indie Asset Partners LLC29,652$0.22M0.2%N/A0.250%Search for SEC Filing on Google Icon
11/8/2021CM Management LLC64,327$0.48M0.4%+543.3%0.542%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC50,000$0.50M0.0%N/A0.421%Search for SEC Filing on Google Icon
8/16/2021Telemetry Investments L.L.C.30,293$0.30M0.4%N/A0.255%Search for SEC Filing on Google Icon
8/11/2021Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC10,000$100K0.1%N/A0.084%Search for SEC Filing on Google Icon
5/27/2021Davidson Kempner Capital Management LP15,000$0.22M0.0%N/A0.126%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC15,532$0.23M0.1%N/A0.131%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC14,367$0.21M0.0%N/A0.121%Search for SEC Filing on Google Icon
5/18/2021Greenlight Capital Inc.546,560$8.16M0.6%N/A4.602%Search for SEC Filing on Google Icon
5/18/2021Davidson Kempner Capital Management LP15,000$0.22M0.0%N/A0.126%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC22,754$0.34M0.0%N/A0.192%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Gain Therapeutics logo
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate, GT-02287 for the treatment of GBA1 Parkinson's disease is being evaluated in a Phase I clinical trials. It also has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of Dementia with Lewy Bodies, Alzhiemer's Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is headquartered in Bethesda, Maryland.
Read More on Gain Therapeutics

Today's Range

Now: $1.72
Low: $1.56
High: $1.78

50 Day Range

MA: $2.06
Low: $1.43
High: $2.92

52 Week Range

Now: $1.72
Low: $0.89
High: $5.33

Volume

205,100 shs

Average Volume

267,881 shs

Market Capitalization

$45.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Gain Therapeutics?

Gain Therapeutics' top insider investors include:
  1. Eric I Richman (Director)
  2. Khalid Islam (Chairman)
  3. Jeffrey Scott Riley (Director)
  4. Gene Mack (CEO)
  5. Matthias Alder (CEO)
Learn More about top insider investors at Gain Therapeutics.

Who are the major institutional investors of Gain Therapeutics?

Gain Therapeutics' top institutional shareholders include:
  1. Geode Capital Management LLC — 1.07%
Learn More about top institutional investors of Gain Therapeutics stock.

Which institutional investors are buying Gain Therapeutics stock?

Within the previous quarter, GANX stock was bought by institutional investors including:
  1. Geode Capital Management LLC
In the last year, these company insiders have bought Gain Therapeutics stock:
  1. Eric I Richman (Director)
  2. Khalid Islam (Chairman)
  3. Jeffrey Scott Riley (Director)
  4. Gene Mack (CEO)
Learn More investors buying Gain Therapeutics stock.
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin